This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Fresenius Kabi Ipsum S.r.l.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Tapanjyoti Biswal: Innovator in Pharmaceutical Chemistry
Introduction
Tapanjyoti Biswal is a notable inventor based in Haryana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work has implications for improving the efficacy and safety of medications.
Latest Patents
Tapanjyoti holds a patent for a process for the preparation of sugammadex. This patent describes an improved method that involves reacting a salt of 3-mercapto propionic acid with 6-per-deoxy-6-per-halo-γ-cyclodextrin in a suitable organic solvent. The application also details a crystalline form of a salt of 3-mercapto propionic acid, specifically the disodium salt, and its use in the preparation of sugammadex. This innovation is crucial for enhancing the formulation of this important drug.
Career Highlights
Tapanjyoti is currently employed at Fresenius Kabi Ipsum S.r.l., where he continues to advance his research and development efforts. His work at this esteemed company allows him to collaborate with other experts in the field and contribute to the pharmaceutical industry.
Collaborations
Some of Tapanjyoti's notable coworkers include Walter Cabri and Antonio Ricci. Their collaboration fosters a dynamic environment for innovation and the exchange of ideas in pharmaceutical research.
Conclusion
Tapanjyoti Biswal's contributions to pharmaceutical chemistry, particularly through his patent for the preparation of sugammadex, highlight his role as an innovator in the field. His work not only advances drug formulation but also enhances the overall effectiveness of medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile